Robert Clarke
Direktor/Vorstandsmitglied bei SPEXIS AG
Aktive Positionen von Robert Clarke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SPEXIS AG | Direktor/Vorstandsmitglied | 30.12.2021 | - |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.10.2019 | - |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Vorstandsvorsitzender | 01.01.2020 | - | |
Gründer | 01.01.2020 | - | |
The Johns Hopkins University | Direktor/Vorstandsmitglied | - | - |
Boston University College of Engineering | Direktor/Vorstandsmitglied | - | - |
Alphageneron Pharmaceuticals, Inc.
Alphageneron Pharmaceuticals, Inc. BiotechnologyHealth Technology Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Robert Clarke
Ehemalige bekannte Positionen von Robert Clarke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PULMATRIX, INC. | Direktor/Vorstandsmitglied | 01.01.2012 | 16.05.2019 |
Vorstandsvorsitzender | 01.01.2012 | 16.05.2019 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 | 01.01.2012 | |
Präsident | 01.01.2012 | 16.05.2019 | |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.01.2000 | 01.01.2004 |
Ruthigen, Inc.
Ruthigen, Inc. Pharmaceuticals: MajorHealth Technology Ruthigen, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid based therapeutics designed to prevent and treat infection in invasive applications. Its drug candidate, RUT58-60, is a broad spectrum anti-infective, which is developing for the prevention and treatment of infection in surgical and trauma procedures. The company was founded by Hojabr Alimi on January 18, 2013 and is headquartered in Santa Rosa, CA. | Vorstandsvorsitzender | - | - |
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Robert Clarke
The Johns Hopkins University | Doctorate Degree |
Boston University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Schweiz | 2 |
Operativ
Director/Board Member | 8 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PULMATRIX, INC. | Health Technology |
SPEXIS AG | Health Technology |
Private Unternehmen | 6 |
---|---|
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Ruthigen, Inc.
Ruthigen, Inc. Pharmaceuticals: MajorHealth Technology Ruthigen, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid based therapeutics designed to prevent and treat infection in invasive applications. Its drug candidate, RUT58-60, is a broad spectrum anti-infective, which is developing for the prevention and treatment of infection in surgical and trauma procedures. The company was founded by Hojabr Alimi on January 18, 2013 and is headquartered in Santa Rosa, CA. | Health Technology |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Health Technology |
Alphageneron Pharmaceuticals, Inc.
Alphageneron Pharmaceuticals, Inc. BiotechnologyHealth Technology Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Robert Clarke
- Erfahrung